« Back to Medicines list

albunorm 20%

  • Name:

    albunorm 20%

  • Company:
    info
  • Active Ingredients:

    Human Albumin

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 09/04/20

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 9/4/2020

Click on this link to Download PDF directly

Octapharma Ltd

octapharma

Company Products

Medicine NameActive Ingredients
Medicine Name albunorm 20% Active Ingredients Human Albumin
Medicine Name albunorm 5% Active Ingredients Human Albumin
Medicine Name Fibryga, 1 g, powder and solvent for solution for injection/infusion Active Ingredients Human Fibrinogen
Medicine Name gammanorm Active Ingredients Human Normal Immunoglobulin
Medicine Name LG-octaplas solution for infusion Active Ingredients Human Plasma Proteins
Medicine Name Nuwiq powder and solvent for solution for injection Active Ingredients simoctocog alfa
Medicine Name Octaplex 1000 IU coagulation factor IX per vial, powder and solvent for solution for infusion Active Ingredients Human Prothrombin Complex
Medicine Name Octaplex 500 IU coagulation factor IX per vial, powder and solvent for solution for infusion Active Ingredients Human Prothrombin Complex
Medicine Name Panzyga 100 mg/ml solution for infusion Active Ingredients Human Normal Immunoglobulin
Medicine Name Wilate powder and solvent for solution for injection Active Ingredients Factor VIII, von Willebrand factor
1 - 0 of 10 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 9 April 2020

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use

Updated on 9 April 2020 PIL

Reasons for updating

  • Change to section 2 - excipient warnings

Updated on 9 April 2020 PIL

Reasons for updating

  • Change to section 2 - excipient warnings

Updated on 9 April 2020 PIL

Reasons for updating

  • Change to section 2 - excipient warnings

Updated on 9 April 2020 PIL

Reasons for updating

  • Change to section 2 - excipient warnings

Updated on 9 April 2020

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use

Updated on 18 June 2019

Reasons for updating

  • File format updated to PDF

Free text change information supplied by the pharmaceutical company

Updated file format

Updated on 15 August 2018

Reasons for updating

  • File format updated to PDF

Updated on 15 August 2018

Reasons for updating

  • File format updated to PDF

Updated on 29 May 2018

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - Marketing authorisation number(s)

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 21 May 2018 PIL

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number

Updated on 15 November 2016 PIL

Reasons for updating

  • New PIL for new product

Updated on 15 November 2016 PIL

Reasons for updating

  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 8 March 2016 PIL

Reasons for updating

  • Change of manufacturer
  • Change to date of revision

Updated on 12 February 2015

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 12 February 2015 PIL

Reasons for updating

  • New PIL for medicines.ie